Skip to main content
. 2016 Jun 25;7(30):47966–47974. doi: 10.18632/oncotarget.10299

Table 2. Stratification analysis of rs9660710 and rs763354 genotypes associated with NSCLC risk.

Variables rs9660710 (CC/CA/AA)a OR (95% CI)b Pc rs763354 (GG/GA/AA)a OR (95% CI)b Pc
Cases Controls Cases Controls
Age (years)
 < 60 187/293/109 334/397/142 1.18
(1.01–1.37)
1.000 210/276/100 309/416/147 0.99
(0.85–1.15)
0.040
 ≤ 60 244/376/131 412/533/164 1.18
(1.02–1.35)
276/364/110 341/549/205 0.80
(0.70–0.92)
Gender
 Male 310/477/161 504/649/205 1.13
(1.00–1.27)
0.296 357/439/149 446/677/233 0.86
(0.76–0.97)
0.443
 Female 121/192/79 242/281/101 1.27
(1.06–1.53)
129/201/61 204/288/119 0.94
(0.77–1.13)
Smoking
 Never 175/254/93 389/469/162 1.14
(0.98–1.33)
0.624 186/251/85 342/492/175 0.95
(0.81–1.11)
0.256
 Ever 256/415/147 357/461/144 1.20
(1.05–1.38)
300/389/125 308/473/177 0.84
(0.73–0.97)
Histological types
 Squamous cell carcinoma 151/231/99 746/930/306 1.28
(1.10–1.49)
0.206 172/234/73 650/965/352 0.86
(0.74–1.00)
0.725
 Adenocarcinoma 280/438/141 746/930/306 1.13
(1.00–1.27)
314/406/137 650/965/352 0.89
(0.79–1.00)
a

Major homozygote/heterozygote/minor homozygote.

b

Adjusted for age, gender and smoking where appropriate in additive model.

c

P values were from heterogeneity test based on χ2-based Q test.

Bold values are statistically significant.